Clinical Trial Update: A Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics (PK) of a Single Intravenous (IV) TAK-954 [Phase 1]

View source ↗

Summary

Phase 1 study assessing how renal impairment and dialysis affect the pharmacokinetics of a single IV dose of TAK-954; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Impairment

Drugs mentioned

• TAK-954

Snippet

Sponsor: Takeda | Conditions: Renal Impairment, Healthy Volunteers | Phase 1 | Status: COMPLETED | Results posted: 2020-08-25